Kyobo Life chairman opts not to testify in case against investor group Move widely predicted by legal experts
Translated by Ryu Ho-joung 공개 2021-12-03 08:14:19
이 기사는 2021년 12월 02일 08:05 thebell 에 표출된 기사입니다.
As expected by many legal experts, Kyobo Life Insurance’s chairman Shin Chang-jae has opted not to take the stand in the case against the company’s financial investors and their accounting firm.The Seoul Central District Court said that Shin’s application for non-attendance was filed on Tuesday.
Last month the Kyobo Life chairman was called to attend the seventh hearing scheduled for Wednesday. But with the absence of the key witness, only the examination of documentary evidence was conducted at the latest hearing.
Whether Shin would testify had been one of the biggest questions of the trial. At the sixth hearing held on November 12, attorneys for the South Korean insurer’s financial investors and Deloitte Anjin’s accountants – who were indicted by prosecutors earlier this year for allegedly conspiring to misprice the company’s shares – sought to call Shin as a witness, arguing that he needs to testify as a direct counterparty in the shareholder agreement with the investors.
“Previous witnesses have no knowledge of the history and content of the shareholder agreement or terms related to an initial public offering and put options,” the attorneys said at the sixth hearing, requesting Shin’s attendance in court to better judge the adequacy and independence of the share valuation conducted by Deloitte Anjin.
The court accepted the attorneys’ argument on conditions that Shin’s attendance is not mandatory and the attorneys’ cross-examination is limited to two hours in order to prevent further expansion of the case’s issues.
The legal battle has been ongoing for several months. Last year, Shin and Kyobo Life reported the investors and Deloitte Anjin to prosecutors, arguing that they colluded to wrongfully inflate a price estimate for the company’s shares subject to the put options.
The latest twist came on November 16 when Kyobo Life’s board of directors, chaired by Shin, abruptly decided to restart a process to take the company public next year, a move widely seen as Shin seeking to deescalate the dispute with the investors.
Meanwhile, the investors – consisting of Affinity Equity Partners, IMM Private Equity, Baring Private Equity Asia and Singapore’s GIC – are blaming Shin for failing to fulfill the shareholder agreement.
They also filed an injunction with the Seoul Northern District Court separately to force Shin to start a process to estimate the value of shares subject to the put options, with the court’s decision expected as soon as early December.
The ruling on the case against the investor group and accountants from Deloitte Anjin is expected to come before the end of this year. (Reporting by Ha-na Suh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '재무개선' AJ네트웍스, 조달비용 '확' 낮췄다
- '9년만에 엑시트' 한앤코, 한온시스템 거래구조 살펴보니
- 한국타이어앤테크놀로지, 한온시스템 인수한다
- [수술대 오른 커넥트웨이브]2대주주 지분매입 나선 MBK, 주식교환 카드 꺼냈다
- [이사회 모니터]이재용 에이비프로바이오 대표, 바이오·반도체 신사업 '드라이브'
- 와이투솔루션, 주인 바뀌어도 '신약' 중심엔 美 합작사 '룩사'
- 아이티센, 부산디지털자산거래소 본격 출범
- 아이에스시, AI·데이터센터 수주 증가에 '날개'
- [이사회 모니터]서정학 IBK증권 대표, ESG위원회도 참여 '영향력 확대'
- SW클라우드 '10주년' 폴라리스오피스, “초격차 밸류업”